Mutschler 2022 MitoFit

From Bioblast
Revision as of 10:48, 15 April 2022 by Tindle Lisa (talk | contribs)
Jump to navigation Jump to search


MitoFit Preprints         MitoFit Preprints        
Gnaiger 2019 MitoFit Preprints
       
Gnaiger MitoFit Preprints 2020.4
        MitoFit DOI Data Center         MitoPedia: Preprints


Mutschler 2022 MitoFit

Publications in the MiPMap
Mutschler R (2022) Membranes as therapeutic targets - liposomes as therapeutic options. MitoFit Preprints 2022.10. https://doi.org/10.26124/mitofit:2022-0010

»

MitoFit pdf

Membranes as therapeutic targets - liposomes as therapeutic options

Mutschler Rainer (2022-04-07) MitoFit Prep

Abstract: Damaged or chemically altered membranes are highly likely to play a central role at the molecular level in many chronic and acute diseases as well as in aging. Damage is often related to inflammatory processes that release large amounts of radical oxygen species (ROS). For several years, membrane replacement has been investigated as a therapeutic option for various diseases. Furthermore, liposomes represent potentially valuable tools for this purpose to force the integration of membrane material into the body's own tissue. Unfortunately, however, this method has not yet arrived in practice. Therefore, we have made our own efforts to establish membrane replacement in our practice, including the therapeutic use of liposomal products of high quality. Here we report on two successfully treated cases.

Keywords: membranes, liposomes, phospholipids, phosphatidylcholine, membrane replacement therapy, liposomal formulations, mitochondria, adducts, detoxification Bioblast editor: Tindle-Solomon L



Labels: MiParea: Patients  Pathology: Inherited, Parkinson's  Stress:Oxidative stress;RONS  Organism: Human 





membranes, liposomes, lipids, Bioblast 2022